Commission Implementing Regulation (EU) 2023/515 of 8 March 2023 renewing the approval of the active substance abamectin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)
| Amendments and corrections | |
|---|---|
| April 1, 2023 | Application - See Art 3 |
| March 12, 2023 | Entry into force - Date pub. +3 See Art 3 |
| Consolidated texts |
|---|